Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

PHASE3TerminatedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

March 9, 2023

Study Completion Date

June 20, 2023

Conditions
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)Anemia
Interventions
DRUG

Roxadustat

Oral tablets

DRUG

Placebo

Oral tablets

Trial Locations (124)

1200

Investigational Site, Brussels

2010

Investigational Site, Darlinghurst

2170

Investigational Site, Liverpool

2610

Investigational Site, Wilrijk

3021

Investigational Site, Victoria Park

3500

Investigational Site, Hasselt

4101

Investigational Site, South Brisbane

5000

Investigational Site, Odense

5100

Investigational Site, Terni

5530

Investigational Site, Yvoir

6500

Investigational Site, Ankara

7000

Investigational Site, Hobart

8000

Investigational Site, Bruges

15121

Investigational Site, Alessandria

16132

Investigational Site, Genova

19106

Investigational Site, Philadelphia

20089

Investigational Site, Milan

20900

Investigational Site, Monza

21100

Investigational Site, Varese

21565

Investigational Site, Incheon

Investigational Site, Incheon

22100

Investigational Site, Nahariya

22908

Investigational Site, Charlottesville

28007

Investigational Site, Madrid

28034

Investigational Site, Madrid

28050

Investigational Site, Madrid

28204

Investigational Site, Charlotte

29414

Investigational Site, Charleston

30322

Investgational site, Atlanta

30912

Investigational Site, Augusta

31008

Investigational Site, Pamplona

33028

Investigational Site, Pembroke Pines

33110

Investigational Site, Yenişehir

33331

Investiational Site, Weston

35340

Investigational Site, Izmir

37007

Investigational Site, Salamanca

37044

Investigational Site, Tours

38039

Investigational Site, Kayseri

38043

Investigational Site, Grenoble

40138

Investigational Site, Bologna

40225

Investigational Site, Düsseldorf

40479

Investigational Site, Düsseldorf

41009

Investigational Site, Seville

41013

Investigational Site, Seville

44111

Investigational Site, Cleveland

44124

Investigational Site, Mayfield Heights

44195

Investigational Site, Cleveland

44718

Investigational Site, Canton

46026

Investigational Site, Valencia

47014

Investigational Site, Meldola

48149

Investigational Site, Münster

49372

Investigational Site, Tel Aviv

50134

Investigational Site, Florence

58128

Investigational Site, Hwasun

59100

Investigational Site, Izmir

Investigational Site, Tekirdağ

63110

Investigational Site, St Louis

70300

Investigational Site, Ẕerifin

73100

Investigational Site, Lecce

77030

Investigational Site, Houston

79106

Investigational Site, Freiburg im Breisgau

81501

Investigational Site, Grand Junction

81675

Investigational Site, München

89124

Investigational Site, Reggio Calabria

90095

Investigational Site, Los Angeles

90212

Investigational Site, Beverly Hills

Investigational Site, Burbank

90505

Investigational Site, Torrance

90603

Investigational Site, Whittier

91105

Investigational Site, Pasadena

91326

Investigational Site, Los Angeles

91355

Investigational Site, Valencia

91361

Investigational Site, Westlake Village

91436

Investigational Site, Encino

92056

Investigational Site, Oceanside

92653

Investigational Site, Laguna Hills

93003

Investigational Site, Ventura

93309

Investigational Site, Bakersfield

93454

Investigational Site, Santa Maria

111123

Investigational Site, Moscow

123182

Investigational Site, Moscow

129110

Investigational Site, Moscow

191024

Investigational Site, Saint Petersburg

197022

Investigational Site, Saint Petersburg

197089

Investigational Site, Saint Petersburg

197341

Investigational Site, Saint Petersburg

248007

Investigational Site, Kaluga

644013

Investigational Site, Omsk

700014

Investigational Site, Kolkata

3436212

Investigational Site, Haifa

4428164

Investigational Site, Kfar Saba

5265601

Investigational Site, Ramat Gan

Unknown

Investigational Site, Brussels

Investigational Site, Paris

Investigational site, Tel Litwinsky

Investigational Site, Rimini

Investigational Site, Torino

V6E 1M7

Investigational Site, Vancouver

N6A5W9

Investigational Site, London

06200

Investigational Site, Nice

01307

Investigational Site, Dresden

04103

Investigational Site, Leipzig

632 004

Investigational Site, Vellore

00133

Investigational Site, Roma

15-732

Investigational Site, Bialystok

85-168

Investigational Site, Bydgoszcz

31-513

Investigational Site, Krakow

64-920

Investigational Site, Piła

60-185

Investigational Site, Skorzewo

76-200

Investigational Site, Słupsk

02-172

Investigational Site, Warsaw

06351

Investigational Site, Seoul

03080

Investigational Site, Seoul

08208

Investigational Site, Sabadell

08003

Investigational Site, Barcelona

08035

Investigational Site, Barcelona

08041

Investigational Site, Barcelona

08908

Investigational Site, Barcelona

06590

Investigational Site, Dikimevi

PE21 9QS

Investigational Site, Boston

OX3 7LE

Investigational Site, Headington

HA1 3UJ

Investigational Site, Harrow

SE5 9RS

Investigational Site, London

M20 4BX

Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Astellas Pharma Inc

INDUSTRY

lead

FibroGen

INDUSTRY